2025-11-06 - Analysis Report
Okay, here's a comprehensive analysis of Sempra (SRE) based on the data you provided.  I'll follow your requested format.

## Sempra (SRE) Analysis

**Company Overview:** Sempra is an energy infrastructure company that develops and owns energy infrastructure with a focus on markets in North America.

### 1. Performance vs. S&P 500 (VOO)

*   **SRE Cumulative Return:** 20.04%
*   **VOO Cumulative Return:** 99.52%
*   **Absolute Deviation:** -84.0% (SRE underperformed VOO significantly)
*   **Relative Deviation:** 8.0% (SRE's underperformance is near the lower end of its historical range compared to VOO)

**Analysis of Performance Table:**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | 8.0%   | 70.6% | -20.0%  | 0.0    | 34.9   |
| 2016-2018  | 11.0%  | 71.1% | -4.0%   | 0.1    | 35.3   |
| 2017-2019  | 35.0%  | 71.1% | 13.0%   | 0.3    | 49.4   |
| 2018-2020  | -4.0%  | 80.1% | -28.0%  | 0.2    | 41.6   |
| 2019-2021  | -2.0%  | 80.1% | -49.0%  | 0.4    | 43.2   |
| 2020-2022  | -15.0% | 81.1% | -14.0%  | 0.4    | 50.4   |
| 2021-2023  | 22.0%  | 81.1% | 20.0%   | 0.5    | 48.8   |
| 2022-2024  | 11.0%  | 81.1% | -10.0%  | 0.6    | 57.2   |
| 2023-2025  | -9.0%  | 74.5% | -73.0%  | -0.1   | 60.6   |

*   **CAGR:** Fluctuates significantly, showing inconsistent growth.  The most recent period (2023-2025) shows a decline.
*   **MDD (Maximum Drawdown):** High MDD values indicate substantial potential losses during downturns. MDD는 전반적으로 매우 높으며, 이는 투자에 위험이 수반됨을 시사합니다.
*   **Alpha:**  Alpha is frequently negative, suggesting SRE often underperforms relative to its risk (Beta).
*   **Beta:**  Beta values are generally low, indicating SRE is less volatile than the overall market. 0에 가까운 베타는 시장 변동에 민감도가 낮다는 것을 시사합니다.
*   **Market Cap:** Showing growth over time.

**Summary:** SRE has significantly underperformed the S&P 500 over the specified period. While its volatility is lower than the market, its negative Alpha suggests it doesn't generate excess returns for the risk taken.

### 2. Recent Price Action

*   **Current Price:** 92.84
*   **Last Market Price:** 92.86 (change: 0.41 compared to the previous close of 92.48) - There is a slight price increase.
*   **5-day Moving Average:** 92.4
*   **20-day Moving Average:** 92.02
*   **60-day Moving Average:** 86.75

**Analysis:** The current price is above all the moving averages, suggesting a short-term upward trend.  The recent price increase confirmed by "Last Market Price" is relatively small (0.41) and does not suggest a major volatility event.

### 3. Market Risk Indicators and Expected Return

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 53.61 (Neutral - neither overbought nor oversold)
*   **PPO (Percentage Price Oscillator):** -0.319 (Slightly bearish, suggesting the short-term moving average is below the long-term moving average)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (116 shares - Very Safe - MRI:0.90) (Cash Ratio: 0% on 2025-09-16) - The hybrid signal recommends to "buy 100% of cash"
*   **Delta_Previous_Relative_Divergence (20-day):** -4.2 (Negative - indicating a recent short-term decline in relative performance)
*   **Expected Return (%):** -373.5 (Very Negative - projects significant underperformance vs. the S&P 500 over a long-term investment horizon)

**Analysis:** While the MRI suggests a high investment recommendation due to overall market conditions, other indicators paint a mixed picture. The negative PPO and declining relative divergence suggest recent weakness.  The extremely negative expected return is a major red flag.

### 4. Recent News & Significant Events

*   **Series of News Articles (November 5, 2025):** All headlines indicate positive Q3 earnings reports, with Sempra beating estimates and reaffirming its outlook.

**Impact:**  Positive earnings news could provide a short-term boost to the stock price.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (~1.94 on a 1-5 scale)
*   **Target Price:** Average: 95.67, High: 115.00, Low: 80.00
*   **Recent Rating Changes:** No changes are available in provided data

**Analysis:** Analysts are generally positive on SRE, with a "Buy" consensus and an average target price slightly above the current price.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-08-07 | 0.71 | 2.70 B$  |
| 2025-05-08 | 1.39 | 3.68 B$  |
| 2024-11-06 | 1.01 | 2.57 B$  |
| 2024-08-06 | 1.13 | 2.48 B$  |
| 2025-08-07 | 1.13 | 2.48 B$  |

**Analysis:**

*   EPS and revenue fluctuate. The most recent EPS (1.13) is same as previous EPS on 2024-08-06.
*   revenue fluctuate. The most recent revenue (2.48B) is less than previous revenue (2.57B) on 2024-11-06.
*   There is no clear trend of consistent earnings or revenue growth.

### 6. Financial Information

| Quarter    | Revenue    | Profit Margin |
|------------|------------|---------------|
| 2025-06-30 | $3.00B     | 46.73%        |
| 2025-03-31 | $3.80B     | 47.21%        |
| 2024-12-31 | $3.76B     | 49.23%        |
| 2024-09-30 | $2.78B     | 44.49%        |
| 2024-06-30 | $3.01B     | 44.20%        |

| Quarter    | Equity      | ROE      |
|------------|-------------|----------|
| 2025-06-30 | $31.72B    | 1.49%    |
| 2025-03-31 | $31.66B    | 2.90%    |
| 2024-12-31 | $31.24B    | 2.16%    |
| 2024-09-30 | $29.72B    | 2.18%    |
| 2024-06-30 | $29.50B    | 2.46%    |

**Analysis:**

*   **Revenue:** Fluctuates quarter to quarter with no clear upward trend.
*   **Profit Margin:**  Margins are relatively stable.
*   **Equity:** Slowly increasing, suggesting some accumulation of wealth.
*   **ROE (Return on Equity):**  ROE is relatively low, indicating that Sempra is not generating high returns on shareholder equity.

### 7. Overall Conclusion

Based on the provided data, Sempra (SRE) presents a mixed investment picture:

*   **Negative Factors:**
    *   Significant underperformance compared to the S&P 500.
    *   Negative Alpha, indicating underperformance relative to risk.
    *   Extremely negative expected return over the long term.
    *   Fluctuating revenue and earnings with no clear trend.
    *   Relatively low ROE.
*   **Positive Factors:**
    *   Recent positive earnings news.
    *   "Buy" consensus from analysts.
    *   MRI suggesting a favorable market environment.
    *   Relatively low Beta (less volatile than the market).
*   **Neutral Factors:**
    *   RSI indicating a neutral market condition

**Investment Recommendation:**

While recent positive earnings and analyst sentiment are encouraging, the significant historical underperformance, negative expected return, and fluctuating financials raise concerns.  **A cautious approach is warranted.** Further due diligence is necessary to understand the reasons for the underperformance and to assess whether Sempra can improve its profitability and generate better returns in the future.  The extremely negative expected return should be investigated thoroughly. Before making any investment decisions, consider your risk tolerance and investment goals.
